-
1Academic Journal
المؤلفون: Kasius, J.C., Pijnenborg, J.M.A., Lindemann, K., Forsse, D., van Zwol, J., Kristensen, G.B., Krakstad, C., Werner, H.M.J., Amant, F.
المصدر: Kasius , J C , Pijnenborg , J M A , Lindemann , K , Forsse , D , van Zwol , J , Kristensen , G B , Krakstad , C , Werner , H M J & Amant , F 2021 , ' Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification ' , Cancers , vol. 13 , no. 22 , 5848 . https://doi.org/10.3390/cancers13225848
مصطلحات موضوعية: endometrial cancer, uterine neoplasm, surgical staging, FIGO stage, molecular classification, TCGA, ProMisE, TRANSPORTEC, LYMPH-NODE METASTASIS, CIRCULATING TUMOR-CELLS, PHASE-III TRIAL, PERITONEAL CYTOLOGY, INTEROBSERVER VARIABILITY, PROSPECTIVE MULTICENTER, PROGNOSTIC-SIGNIFICANCE, ADJUVANT CHEMOTHERAPY, HIGH-INTERMEDIATE, ASTEC TRIAL
-
2
المصدر: Cancers. 13(22)
مصطلحات موضوعية: molecular classification, LYMPH-NODE METASTASIS, PHASE-III TRIAL, HIGH-INTERMEDIATE, FIGO stage, TCGA, surgical staging, CIRCULATING TUMOR-CELLS, uterine neoplasm, INTEROBSERVER VARIABILITY, ADJUVANT CHEMOTHERAPY, ASTEC TRIAL, TRANSPORTEC, endometrial cancer, PROGNOSTIC-SIGNIFICANCE, PERITONEAL CYTOLOGY, ProMisE, PROSPECTIVE MULTICENTER
-
3Academic Journal
المؤلفون: Farrell, Rhonda, Dixon, Suzanne C., Carter, Jonathan, Webb, Penny M., For the Australian National Endometrial Cancer Study Group
مصطلحات موضوعية: Endometrial cancer, Endometrioid, Intermediate, high risk, Lymphadenectomy, Lymphoedema, Surgical morbidity, Papillary Serous Carcinoma, Supportive Care Needs, Astec Trial, Survival, Adenocarcinoma, Therapy, 2729 Obstetrics and Gynaecology, 2730 Oncology
Relation: orcid:0000-0003-0733-5930; 339435; 403031; 457636; 552468; Not set
-
4Academic Journal
مصطلحات موضوعية: Oncology and carcinogenesis not elsewhere classified, Science & Technology, Life Sciences & Biomedicine, Oncology, Obstetrics & Gynecology, Endometrial cancer, Endometrioid, Intermediate, high risk, Lymphadenectomy, Lymphoedema, Surgical morbidity, PAPILLARY SEROUS CARCINOMA, SUPPORTIVE CARE NEEDS, ASTEC TRIAL, SURVIVAL, ADENOCARCINOMA, THERAPY, 3211 Oncology and carcinogenesis